Ventsislav Dobrev

Digital Biomarker (dBM)⚡️Drug Development | Global Clinical Integration Lead dBMs @ Roche | Board Advisor | Angel Investor

📍 Switzerland🔄 Updated September 2026💼 2 investments📅 1 years investing🗓 Last invested Jul 2025
VC🌍 Switzerland
2
Total investments
1
Early stage
1
Mid stage
0
Late stage
1y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Member / Angel Investor
Jul 2025
As a group of experienced, diverse, and inclusive professionals we have been investing in healthcare startups across Europe over the last 8 years. We have built, and continue to grow, a diverse portfolio of investments across the various fields of therapeutics, diagnostics and digital health. Through our broad presence in the European Healthcare field, we are also able to facilitate investment activities for institutional investors with our curated healthcare deals. We value close personal dialogue with diverse startup teams and bring smart money to the table. Startups have access to a large group of experts in all areas and regions, and if we invest, to a longterm engagement and commitment from us.
Member / Angel Investor
Mar 2025
Fuel the Future of Healthcare Invest in the most promising HealthTech Startups and play a key role in shaping the future of healthcare. MEDKAP Investor Association is a Swiss non-profit organisation. We identify high-potential early-stage startups in the fields of digital health, medtech and diagnostics (Healthtech) and enable our members to build a diversified portfolio. We encourage best-of-breed approaches to bring the startup quicker to success. Sign up to our newsletter: https://share-eu1.hsforms.com/1-TICJNa4Sw2v94dmMykyPQg0y4n
Experience · 3 entries
All (3)
Investments (2)
2025
Member / Angel Investor
Jul 2025
As a group of experienced, diverse, and inclusive professionals we have been investing in healthcare startups across Europe over the last 8 years. We have built, and continue to grow, a diverse portfolio of investments across the various fields of therapeutics, diagnostics and digital health. Through our broad presence in the European Healthcare field, we are also able to facilitate investment activities for institutional investors with our curated healthcare deals. We value close personal dialogue with diverse startup teams and bring smart money to the table. Startups have access to a large group of experts in all areas and regions, and if we invest, to a longterm engagement and commitment from us.
Member / Angel Investor
Mar 2025
Fuel the Future of Healthcare Invest in the most promising HealthTech Startups and play a key role in shaping the future of healthcare. MEDKAP Investor Association is a Swiss non-profit organisation. We identify high-potential early-stage startups in the fields of digital health, medtech and diagnostics (Healthtech) and enable our members to build a diversified portfolio. We encourage best-of-breed approaches to bring the startup quicker to success. Sign up to our newsletter: https://share-eu1.hsforms.com/1-TICJNa4Sw2v94dmMykyPQg0y4n
2008
Clinical Research Associate (CRA)
Jan 2008
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.